Interactions between metabolic disorders [diabetes, gallstones, and dyslipidaemia] and the progression of chronic hepatitis C virus infection to cirrhosis and hepatocellular carcinoma. A cross-sectional multicentre survey

Digestive and Liver Disease

Volumn 33, Issue 3, 2001, Pages 240-246

  Cimino, L ^a   Oriani, G ^b   D'Arienzo, A ^a   Manguso, F ^a   Loguercio, C ^d   Ascione, A ^c   Caporaso, N ^a   Del Vecchio Blanco, C ^d   Budillon, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

^c CARDARELLI HOSPITAL   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cholestasis; Diabetes; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHOLELITHIASIS; CHOLESTASIS; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETES MELLITUS; DISEASE COURSE; DYSLIPIDEMIA; ENZYME ACTIVITY; FEMALE; GALLSTONE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTICENTER STUDY; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; STAGING; STATISTICAL MODEL; VIRUS INFECTION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHOLELITHIASIS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HEPATITIS C, CHRONIC; HUMANS; HYPERLIPIDEMIAS; INCIDENCE; ITALY; LINEAR MODELS; LIVER NEOPLASMS; MALE; METABOLIC DISEASES; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

EID: 0035003871     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Katbamna BH, Petrelli M, McCullough AJ. The liver in diabetes mellitus and hyperlipidemia. In: Gitlin N, editor. The liver and systemic disease. New York: Churchill Livingstone; 1997. p. 73-113.
2. Creutzfeldt W, Frerichs H, Sickinger K. Liver disease and diabetes mellitus. In: Popper H, Schaffner F, editors. Progress in liver disease. Vol. III. New York: Grune and Stratton, 1970. p. 371-407.
3. Attili AF, Capocaccia R, Carulli N, Festi D, Roda E, Barbara L, et al. Factors associated with gallstone disease in the MICOL experience. Hepatology 1997;26:809-18.
4. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos study. Hepatology 1994;20:1442-9.
5. Chiaramonte M, Stroffolini T, Caporaso N, Coppola R, Craxi A, Gaeta GB, et al. Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study (a report from the HCV study group of the Italian Association for the Study of the Liver). Ital J Gastroenterol Hepatol 1991;23:555-8.
6. Chiaramonte M, Stroffolini T, Lorenzoni U, Minniti F, Conti S, Floreani A, et al. Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy. J Hepatol 1996;24:129-34.
7. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994;21:1135-9.
8. Del Vecchio Blanco C, Gentile S, Marmo R, Carbone L, Coltorti M. Alterations of glucose metabolism in chronic liver disease. Diabetes Res Clin Pract 1990;8:29-36.
9. Gentile S, Loguercio C, Marmo R, Carbone L, Del Vecchio Blanco C. Incidence of altered glucose tolerance in liver cirrhosis. Diabetes Res Clin Pract 1993;22:37-44.
10. Castellano L, De Sio I, Silvestrino F, Marmo R, Del Vecchio Blanco C. Cholelithiasis in patients with chronic active liver disease: evaluation of risk factors. Ital J Gastroenterol 1995;27:425-9.
11. Friedman GD, editor. Primer of epidemiology. 4th ed. New York: McGraw Hill; 1994.
12. SPSS advanced models 10.0. Chicago: SPSS, 1999. p. 147-203.
13. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-97.
14. Liberati A, Blum AL, Apolone G, Nicolucci A. Basic principles for use and interpretation of epidemiologic data. In: Chalmers TC, editor. Data analysis for clinical medicine: the quantitative approach to patient care in gastroenterology. Rome: International University Press, 1988. p. 42.
15. Bailar JC III, Louis TA, Lavori PW, Polansky M. A classification for biomedical research reports. N Engl J Med 1984;311:1482-7.
16. Hadziyannis S, Karamanos B. Diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999;29:604-5.
17. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107:1103-9.
18. Zein NN. Hepatitis C and diabetes mellitus: an ongoing controversy. Am J Gastroenterol 1998;93:2320-2.
19. Mason AL, Johnson Y, Lau N, Qian K, Alexander GJ, Xu L, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999;29:328-33.
20. D'Amora M, Iengo A, Risitano N, Risitano A, Barone G, Garcea P, et al. Valutazione del metabolismo glucidico, urico e lipidico nella popolazione della provincia di Napoli. Quad Med Chir 1996;12:170-4.
21. Vaccaro O, Imperatore G, Ferrara A, Palombino R, Riccardi G. Epidemiology of diabetes mellitus in southern Italy: a case-finding method based on drug prescriptions. J Clin Epidemiol 1992;45:835-9.
22. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med 1998;339:1217-27.
23. Beuers U, Boyer JL, Paumgartner G. Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications. Hepatology 1998;28:1449-53.
24. Trauner M, Graziadei IW. Review article: mechanism of action and therapeutic applications of Ursodeoxycholic acid in chronic liver diseases. Aliment Pharmacol Ther 1999;13:979-95.
25. Huo TI, Wu JC, Lee PC, Tsay SH, Chang FY, Lee SD. Diabetes mellitus as a risk factor of liver cirrhosis in patients with chronic hepatitis B virus infection. J Clin Gastroenterol 2000;30:250-4.
26. Han SH, Martin P. Diabetes mellitus: a predictor of cirrhosis in chronic viral hepatitis. J Clin Gastroenterol 2000;30:227-8.
27. Hourigan LF, Macdonald GA, Purdie D, Whitehall VH, Shorthouse C, Clouston A, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999;29:1215-9.
28. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-50.
29. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 2000;21:49-98.
30. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000;343:1467-76
31. Bateson MC. Commentary: gallstone epidemiology. Ital J Gastroenterol Hepatol 1997;29:335-7.
32. Conte D, Fraquelli M, Fornari F, Lodi L, Bodini P, Buscarini L. Close relation between cirrhosis and gallstones: cross-sectional and longitudinal survey. Arch Intern Med 1999;159:49-52.
33. Maggi A, Solenghi D, Panzeri A, Borroni G, Cazzaniga M, Sangiovanni A, et al. Prevalence and incidence of cholelithiasis in patients with liver cirrhosis. Ital J Gastroenterol Hepatol 1997;29:330-5.
34. Cicognani C, Malavolti M, Morselli-Labate AM, Zamboni L, Sama C, Barbara L. Serum lipid and Iipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med 1997;157:792-6.
35. D'Arienzo A, Manguso F, Scaglione G, Vicinanza G, Bennato R, Mazzacca G. Prognostic value of progressive decrease in serum cholesterol in predicting survival in Child-Pugh C viral cirrhosis. Scand J Gastroenterol 1998;33:1213-8.
36. Matas C, Joven J, Vilella E, Cliville X, Cabre M, Prats E, et al. Lipoprotein alterations in liver cirrhosis: a possible contribution to changes in plasma oncotic pressure and viscosity. J Hepatol 1997;27:639-44.
37. Seidel D. Lipoproteins in liver disease. J Clin Chem Clin Biochem 1987;25:541-51.
38. Sabesin SM. Lipid and lipoprotein abnormalities in alcoholic liver disease. Circulation 1981;64:72-84.
39. Camps J, Pizzarro I, Prats E, La Ville A, Turner PR, Masana L, et al. Plasma lipoprotein alterations in patients with chronic hepatocellular liver disease resulting from alcohol abuse: effects of alcohol intake cessation. J Hepatol 1994;21:704-9.